Literature DB >> 22661704

Myosin regulatory light chain diphosphorylation slows relaxation of arterial smooth muscle.

Cindy Sutherland1, Michael P Walsh.   

Abstract

The principal signal to activate smooth muscle contraction is phosphorylation of the regulatory light chains of myosin (LC(20)) at Ser(19) by Ca(2+)/calmodulin-dependent myosin light chain kinase. Inhibition of myosin light chain phosphatase leads to Ca(2+)-independent phosphorylation at both Ser(19) and Thr(18) by integrin-linked kinase and/or zipper-interacting protein kinase. The functional effects of phosphorylation at Thr(18) on steady-state isometric force and relaxation rate were investigated in Triton-skinned rat caudal arterial smooth muscle strips. Sequential phosphorylation at Ser(19) and Thr(18) was achieved by treatment with adenosine 5'-O-(3-thiotriphosphate) in the presence of Ca(2+), which induced stoichiometric thiophosphorylation at Ser(19), followed by microcystin (phosphatase inhibitor) in the absence of Ca(2+), which induced phosphorylation at Thr(18). Phosphorylation at Thr(18) had no effect on steady-state force induced by Ser(19) thiophosphorylation. However, phosphorylation of Ser(19) or both Ser(19) and Thr(18) to comparable stoichiometries (0.5 mol of P(i)/mol of LC(20)) and similar levels of isometric force revealed differences in the rates of dephosphorylation and relaxation following removal of the stimulus: t(½) values for dephosphorylation were 83.3 and 560 s, and for relaxation were 560 and 1293 s, for monophosphorylated (Ser(19)) and diphosphorylated LC(20), respectively. We conclude that phosphorylation at Thr(18) decreases the rates of LC(20) dephosphorylation and smooth muscle relaxation compared with LC(20) phosphorylated exclusively at Ser(19). These effects of LC(20) diphosphorylation, combined with increased Ser(19) phosphorylation (Ca(2+)-independent), may underlie the hypercontractility that is observed in response to certain physiological contractile stimuli, and under pathological conditions such as cerebral and coronary arterial vasospasm, intimal hyperplasia, and hypertension.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661704      PMCID: PMC3397833          DOI: 10.1074/jbc.M112.371609

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Purification and characterization of the mammalian myosin light chain phosphatase holoenzyme. The differential effects of the holoenzyme and its subunits on smooth muscle.

Authors:  A Shirazi; K Iizuka; P Fadden; C Mosse; A P Somlyo; A V Somlyo; T A Haystead
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

Review 2.  The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1δ.

Authors:  Michael E Grassie; Lori D Moffat; Michael P Walsh; Justin A MacDonald
Journal:  Arch Biochem Biophys       Date:  2011-02-01       Impact factor: 4.013

Review 3.  The biochemical basis of the regulation of smooth-muscle contraction.

Authors:  B G Allen; M P Walsh
Journal:  Trends Biochem Sci       Date:  1994-09       Impact factor: 13.807

Review 4.  Integrin-linked kinase: not so 'pseudo' after all.

Authors:  G E Hannigan; P C McDonald; M P Walsh; S Dedhar
Journal:  Oncogene       Date:  2011-05-23       Impact factor: 9.867

5.  Enhanced contractility and myosin phosphorylation induced by Ca(2+)-independent MLCK activity in hypertensive rats.

Authors:  Young-Eun Cho; Duck-Sun Ahn; Kathleen G Morgan; Young-Ho Lee
Journal:  Cardiovasc Res       Date:  2011-03-04       Impact factor: 10.787

6.  Mutagenesis of the phosphorylation site (serine 19) of smooth muscle myosin regulatory light chain and its effects on the properties of myosin.

Authors:  H Kamisoyama; Y Araki; M Ikebe
Journal:  Biochemistry       Date:  1994-01-25       Impact factor: 3.162

7.  Integrin-linked kinase is a functional Mn2+-dependent protein kinase that regulates glycogen synthase kinase-3β (GSK-3beta) phosphorylation.

Authors:  Mykola Maydan; Paul C McDonald; Jasbinder Sanghera; Jun Yan; Charalampos Rallis; Sheena Pinchin; Gregory E Hannigan; Leonard J Foster; David Ish-Horowicz; Michael P Walsh; Shoukat Dedhar
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

Review 8.  Smooth muscle cell calcium activation mechanisms.

Authors:  Michael J Berridge
Journal:  J Physiol       Date:  2008-09-11       Impact factor: 5.182

9.  Effects of calyculin A on tension and myosin phosphorylation in skinned smooth muscle of the rabbit mesenteric artery.

Authors:  A Suzuki; T Itoh
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

Review 10.  The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase!

Authors:  Sara A Wickström; Anika Lange; Eloi Montanez; Reinhard Fässler
Journal:  EMBO J       Date:  2009-12-24       Impact factor: 11.598

View more
  20 in total

Review 1.  A role for the Ca(2+)-dependent tyrosine kinase Pyk2 in tonic depolarization-induced vascular smooth muscle contraction.

Authors:  Ryan D Mills; Mitsuo Mita; Michael P Walsh
Journal:  J Muscle Res Cell Motil       Date:  2015-07-07       Impact factor: 2.698

2.  Sphingosine-1-phosphate induced contraction of bladder smooth muscle.

Authors:  Derek M Kendig; Alec K Matsumoto; Robert S Moreland
Journal:  Eur J Pharmacol       Date:  2013-10-10       Impact factor: 4.432

3.  Biphasic regulation of myosin light chain phosphorylation by p21-activated kinase modulates intestinal smooth muscle contractility.

Authors:  Ji Chu; Ngoc T Pham; Nicole Olate; Karina Kislitsyna; Mary-Clare Day; Phillip A LeTourneau; Alexander Kots; Randolph H Stewart; Glen A Laine; Charles S Cox; Karen Uray
Journal:  J Biol Chem       Date:  2012-11-16       Impact factor: 5.157

4.  A role for the tyrosine kinase Pyk2 in depolarization-induced contraction of vascular smooth muscle.

Authors:  Ryan D Mills; Mitsuo Mita; Jun-ichi Nakagawa; Masaru Shoji; Cindy Sutherland; Michael P Walsh
Journal:  J Biol Chem       Date:  2015-02-24       Impact factor: 5.157

5.  p21-Activated kinase (Pak) regulates airway smooth muscle contraction by regulating paxillin complexes that mediate actin polymerization.

Authors:  Wenwu Zhang; Youliang Huang; Susan J Gunst
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

6.  Opsin 3 and 4 mediate light-induced pulmonary vasorelaxation that is potentiated by G protein-coupled receptor kinase 2 inhibition.

Authors:  Sebastian Barreto Ortiz; Daijiro Hori; Yohei Nomura; Xin Yun; Haiyang Jiang; Hwanmee Yong; James Chen; Sam Paek; Deepesh Pandey; Gautam Sikka; Anil Bhatta; Andrew Gillard; Jochen Steppan; Jae Hyung Kim; Hideo Adachi; Viachaslau M Barodka; Lewis Romer; Steven S An; Larissa A Shimoda; Lakshmi Santhanam; Dan E Berkowitz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-09-07       Impact factor: 5.464

7.  Cross-talk between Rho-associated kinase and cyclic nucleotide-dependent kinase signaling pathways in the regulation of smooth muscle myosin light chain phosphatase.

Authors:  Michael E Grassie; Cindy Sutherland; Annegret Ulke-Lemée; Mona Chappellaz; Enikö Kiss; Michael P Walsh; Justin A MacDonald
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

8.  Expression of CNPY2 in mouse tissues: quantification and localization.

Authors:  Kota Hatta; Jian Guo; Ana Ludke; Sanjiv Dhingra; Kaustabh Singh; Ming-Li Huang; Richard D Weisel; Ren-Ke Li
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

9.  The p90 ribosomal S6 kinase (RSK) is a mediator of smooth muscle contractility.

Authors:  Mykhaylo Artamonov; Ko Momotani; Darkhan Utepbergenov; Aaron Franke; Alexander Khromov; Zygmunt S Derewenda; Avril V Somlyo
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

10.  Attenuated platelet aggregation in patients with septic shock is independent from the activity state of myosin light chain phosphorylation or a reduction in Rho kinase-dependent inhibition of myosin light chain phosphatase.

Authors:  Benjamin Aj Reddi; Samantha M Iannella; Stephanie N O'Connor; Adam M Deane; Scott R Willoughby; David P Wilson
Journal:  Intensive Care Med Exp       Date:  2015-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.